The making and miniaturizing of microchips has been among the world’s greatest engineering challenges. The semiconductor trade—along with that of an ever-broadening array of electronics enabled by these chips—has been essential to our globalized economy. What should investors focus on now that the United States has begun ambitiously putting more funding and muscle into domestic chip production and industrial policy?
I discussed these themes recently during a conversation with economic historian and Tufts University professor Dr. Chris Miller, who examines the industry’s complex evolution in his new book, Chip War: The Fight for the World’s Most Critical Technology, and with Franklin Equity Group Portfolio Manager JP Scandalios, who has spent more than 20 years researching the semiconductor industry. Here are some key takeaways:
- The world’s economy is reliant upon semiconductor chips. Far beyond just data centers and smartphones, the computing power accessed through microchips is required for all parts of our economy. Cars are increasingly embedded with thousands of microchips, whereas even just a decade ago, they had just a few dozen. We now use chips for credit and debit cards, dishwashers, microwaves—virtually anything with an on/off switch. Advanced microchips are also vital to the defense industry. “Last year, the chip industry produced more transistors than the combined quantity of all goods produced by all other companies, in all other industries, in all human history. Nothing else comes close,” according to Miller. The global chip industry has historically been quite cyclical because of its dependency on personal computers (PCs) and smartphones. With this proliferation, we’ve seen cyclicality begin to dampen and profitability increase significantly. Select semiconductor companies are among the most profitable in the global technology sector, and with cyclicality lessening, this could help drive strong long-term investor returns.
- The process of designing and manufacturing chips is bifurcating. The industry’s trend toward a fabless (without fabrication) model means the users of semiconductors (i.e., Apple) design for their specific needs, while outsourcing the fabrication of the hardware to chip foundries, the largest of which is Taiwan’s Taiwan Semiconductor Manufacturing Company (TSMC). Increasingly, companies running large cloud-computing infrastructures are also building their own chips, including Amazon, Microsoft and Google. The benefit of this is that their application-specific integrated circuits (custom-designed chips) become perfectly honed to their data centers, which will reduce costs. Intel, which has historically designed its own chips, has missed some key shifts in the industry. There is a famous story about how Intel snubbed Apple co-founder Steve Jobs when he asked the firm to produce chips, designed by Apple, for its first iPhone.
- The potential for making chips smaller is itself shrinking. Already measured in billionths of a meter, transistors have been reduced to the size of DNA and virus molecules. Moore’s law of doubling the number of transistors on microchips every two years has become more difficult, forcing companies to be more creative to make chips more effective. Customer demand for new uses and capabilities is propelling that process forward. What we expect to see is a greater share of advances coming from creative chip design versus a continuation of size reduction. A key issue facing the industry is how to package chips so that they can be arranged and assembled in new and innovative ways.
- Today’s underlying competition is largely structured around a differentiated global supply chain. US prowess lies in chip design and the manufacturing of certain machine tools. Japan is quite skilled at producing ultra-purified chemicals used in manufacturing semiconductors. The Netherlands produces the most advanced lithography machines, and Taiwan is unparalleled in its fabrication of the most advanced processor chips. A single company, TSMC, manufactures 90% of the world’s most advanced processor chips.
- Chinese chipmakers rely on manufacturing equipment imported from the United States and the Netherlands. That has left China vulnerable to the type of import restrictions imposed last October. Chips are important to the Chinese economy, which consumes about 25% of all chips made globally, but Chinese producers only manufacture about 8%.1 China, quite remarkably, spends as much to import semiconductors as it spends importing oil.
- The United States is determined to maintain its leadership in semiconductors. The US government’s first goal is to preserve its leadership in research and advanced chip design. Around 20% of the CHIPS Act is dedicated to research.2 It also aims to have the most advanced processor production located domestically. Currently, only three firms in the world can manufacture the most advanced logic semiconductors—Samsung (South Korea), TSMC (Taiwan) and Intel (United States).
- The US government’s drive for new domestic fabrication comes with hefty upfront costs and a complexity that is perhaps second only to the development of nuclear reactors.
We continue to monitor industry developments closely as our economy and everyday lives are more and more dependent on semiconductors.
For the complete webinar, please click on this link.
WHAT ARE THE RISKS?
All investments involve risks, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested.
Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions.
Bond prices generally move in the opposite direction of interest rates. Thus, as prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline.
Investments in fast-growing industries like the technology sector (which historically has been volatile) could result in increased price fluctuation, especially over the short term, due to the rapid pace of product change and development and changes in government regulation of companies emphasizing scientific or technological advancement or regulatory approval for new drugs and medical instruments. Buying and using blockchain-enabled digital currency carries risks, including the loss of principal.
Any companies and/or case studies referenced herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. The information provided is not a recommendation or individual investment advice for any particular security, strategy, or investment product and is not an indication of the trading intent of any Franklin Templeton managed portfolio.
IMPORTANT LEGAL INFORMATION
This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice. This material may not be reproduced, distributed or published without prior written permission from Franklin Templeton.
The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance. All investments involve risks, including possible loss of principal.
Any research and analysis contained in this material has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Data from third party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. The mention of any individual securities should neither constitute nor be construed as a recommendation to purchase, hold or sell any securities, and the information provided regarding such individual securities (if any) is not a sufficient basis upon which to make an investment decision. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user.
Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.
Issued in the U.S. by Franklin Distributors, LLC, One Franklin Parkway, San Mateo, California 94403-1906, (800) DIAL BEN/342-5236, franklintempleton.com – Franklin Distributors, LLC, member FINRA/SIPC, is the principal distributor of Franklin Templeton U.S. registered products, which are not FDIC insured; may lose value; and are not bank guaranteed and are available only in jurisdictions where an offer or solicitation of such products is permitted under applicable laws and regulation.
CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.
1. Source: Macquarie Research, “Tech decoupling and China,” March 10, 2023.
2. The CHIPS and Science Act of 2022 is a legislation signed into law that invests billions in semiconductor and scientific research and development over the next five years to help the United States regain a leading position in semiconductor chip manufacturing.